LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA IN THE UNITED STATES: ECONOMIC BURDEN AND HEALTHCARE UTILIZATION

被引：0
|
作者：
Kearney, M. [1 ]
Esposito, D. [2 ]
Russo, L. [3 ]
Penalvo, J. [4 ]
Yin, R. [2 ]
Lyons, J. [2 ]
Lanes, S. [2 ]
Bharmal, M. [1 ]
机构：
[1] Merck KGaA, Global Evidence & Value Dev, Darmstadt, Germany
[2] HealthCore Inc, Safety & Epidemiol, Andover, MA USA
[3] Pfizer Inc, Collegeville, PA USA
[4] Merck KGaA, Global Epidemiol, Darmstadt, Germany
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN214
引用
收藏
页码：S45 / S45
页数：1
相关论文
共 50 条
  • [1] ECONOMIC BURDEN OF LOCALLY ADVANCED OR METASTATIC MERKEL CELL CARCINOMA IN THE UNITED STATES: AN ANALYSIS OF ELECTRONIC HEALTH RECORDS
    Kearney, M.
    Esposito, D.
    Penalvo, J.
    Russo, L.
    Yin, R.
    Lyons, J.
    Lanes, S.
    Bharmal, M.
    [J]. VALUE IN HEALTH, 2018, 21 : S45 - S45
  • [2] Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma
    Loriot, Y.
    Necchi, A.
    Park, S. H.
    Garcia-Donas, J.
    Huddart, R.
    Burgess, E.
    Fleming, M.
    Rezazadeh, A.
    Mellado, B.
    Varlamov, S.
    Joshi, M.
    Duran, I.
    Tagawa, S. T.
    Zakharia, Y.
    Zhong, B.
    Stuyckens, K.
    Santiago-Walker, A.
    De Porre, P.
    O'Hagan, A.
    Avadhani, A.
    Siefker-Radtke, A. O.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (04): : 338 - 348
  • [3] Erdafitinib for locally advanced or metastatic urothelial carcinoma
    Siefker-Radtke, Arlene O.
    Loriot, Yohann
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (11) : 824 - 825
  • [4] Avelumab in locally advanced or metastatic urothelial carcinoma
    Jackson-Spence, Francesca
    Szabados, Bernadett
    Toms, Charlotte
    Yang, Yu-Hsuen
    Sng, Christopher
    Powles, Thomas
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (02) : 135 - 140
  • [5] HEALTHCARE RESOURCE UTILIZATION AND ECONOMIC BURDEN OF PATIENTS WITH GOUT IN THE UNITED STATES
    Bhattacharya, S.
    Chatterjee, S.
    Kathe, N.
    Agrawal, N.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S592 - S592
  • [6] Maintenance therapy for locally advanced or metastatic urothelial carcinoma
    Rexer, H.
    Banek, S.
    Merseburger, A.
    [J]. UROLOGIE, 2024, 63 (02): : 208 - 209
  • [7] The Economic Burden of Fragile X Syndrome: Healthcare Resource Utilization in the United States
    Sacco, Patricia
    Capkun-Niggli, Gorana
    Zhang, Xin
    Jose, Rosemary
    [J]. AMERICAN HEALTH AND DRUG BENEFITS, 2013, 6 (02): : 73 - 82
  • [8] ECONOMIC BURDEN AND HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH PRURIGO NODULARIS IN THE UNITED STATES
    Huang, A.
    Chavda, R.
    Gabriel, S.
    Canner, J. K.
    Kwatra, S. G.
    [J]. VALUE IN HEALTH, 2020, 23 : S363 - S363
  • [9] Efficacy and tolerability of tremelimumab in locally advanced or metastatic urothelial carcinoma
    Sharma, Padmanee
    Sohn, Joo Hyuk
    Shin, Sang Joon
    Oh, Do-Youn
    Keam, Bhumsuk
    Lee, Hyo Jin
    Canon, Jean-Luc
    Kalinka-Warzocha, Ewa
    Langenberg, Marlies
    Allison, James
    Ben, Yong
    Kataria, Ritesh
    Ferro, Salvatore
    Asubonteng, Kobby
    Dirix, Luc
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [10] ADMISSION RATES, HEALTHCARE UTILIZATION, AND ECONOMIC BURDEN OF RADIATION CYSTITIS (RC) IN THE UNITED STATES
    Arora, Sohrab
    Sood, Akshay
    Dalela, Deepansh
    Borchert, Alex
    Baumgarten, Lee
    Quoc-Dien Trinh
    Rogers, Craig G.
    Peabody, James O.
    Menon, Mani
    Abdollah, Firas
    [J]. JOURNAL OF UROLOGY, 2019, 201 (04): : E1139 - E1139
12345